Galmed Pharmaceuticals

Cambridge Eagle Lab

Galmed is a clinical-stage biopharmaceutical company focused on the development of a novel, once-daily, oral therapy for the treatment of liver diseases utilizing its proprietary first-in-class family of synthetic fatty-acid/bile-acid conjugates, or FABACs.

We believe that our product candidate, AramcholTM, has the potential to be a disease modifying treatment for fatty liver disorders, including non-alcoholic Steatohepatitis, or NASH, which is a chronic disease that we believe constitutes a large unmet medical need.

"I also wanted to meet people and maybe expand my network."

I was looking for a place that had all the facilities I needed in order to work and I was intrigued by the extra curriculum activities offered by Eagle labs, including the CJBS mentoring program. I also wanted to meet people and maybe expand my network. I like it that I have people that I can connect with on a daily basis. 

Want to join the conversation?

Login to start talking with the community below.


Share this page

Go back to the top of the page